Pregnancy Complications
Recent clinical, regulatory, research and industry developments relating to this disease.
Cytokine modulation and immunoregulation of uterine NK cells in pregnancy disorders.
Prioritizing Maternal Mental Health in Addressing Morbidity and Mortality.
Maternal gut microbiota in the health of mothers and offspring: from the perspective of immunology.
The role of maternal hormones in regulating autonomic functions during pregnancy.
Maternal Nutrition and Neurodevelopment: A Scoping Review.
Maternal Immunological Adaptation During Normal Pregnancy.
Application of exosomes as liquid biopsy in clinical diagnosis.
Endometrial Decidualization: The Primary Driver of Pregnancy Health.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 5 clinical trials expected to report results, the earliest in Q3 2026.
- Q3 2026Treatment With Aspirin After Preeclampsia: TAP Trial
- Q4 2026Single Dose of Antenatal Corticosteroids (SNACS) Randomized Controlled Trial for Pregnancies at Risk of Preterm Delivery: To Keep Babies and Children Safe
- Q4 2027Certolizumab to Prevent Pregnancy Complications in High-Risk Patients With APS or SLE - (IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy)
- Q4 2027Randomized Clinical Trial of the Use of Propofol as a Sedative Agent Versus Spinal Analgesia With Bupivacaine in External Cephalic Version
- Q2 2029Azithromycin and Ampicillin for Late PPROM
Clinical MilestonesViewHide
- 2026-02-10The Clinical Carbetocin Myocardium Trial Part 2Results posted
- 2026-06-04Treatment With Aspirin After Preeclampsia: TAP TrialResults expected Q3 2026
- 2026-04-01Certolizumab to Prevent Pregnancy Complications in High-Risk Patients With APS or SLE - (IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy)Results expected Q4 2027
- 2026-01-07Single Dose of Antenatal Corticosteroids (SNACS) Randomized Controlled Trial for Pregnancies at Risk of Preterm Delivery: To Keep Babies and Children SafeResults expected Q4 2026
- 2025-12-18Azithromycin and Ampicillin for Late PPROMResults expected Q2 2029
- 2025-11-21Randomized Clinical Trial of the Use of Propofol as a Sedative Agent Versus Spinal Analgesia With Bupivacaine in External Cephalic VersionResults expected Q4 2027
- 2026-12-01ClinicalA Pilot Study of High Or Low Dose pOstpartUm Oxytocin at the Time of Cesarean Birth (HOLDOUT Pilot)Withdrawn
- 2026-06-04ClinicalTreatment With Aspirin After Preeclampsia: TAP TrialResults expected Q3 2026
- 2026-04-01ClinicalCertolizumab to Prevent Pregnancy Complications in High-Risk Patients With APS or SLE - (IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy)Results expected Q4 2027
- 2026-02-10ClinicalThe Clinical Carbetocin Myocardium Trial Part 2Results posted
- 2026-01-07ClinicalSingle Dose of Antenatal Corticosteroids (SNACS) Randomized Controlled Trial for Pregnancies at Risk of Preterm Delivery: To Keep Babies and Children SafeResults expected Q4 2026
- 2025-12-18ClinicalAzithromycin and Ampicillin for Late PPROMResults expected Q2 2029
- 2025-11-21ClinicalRandomized Clinical Trial of the Use of Propofol as a Sedative Agent Versus Spinal Analgesia With Bupivacaine in External Cephalic VersionResults expected Q4 2027
- 2025-09-30ClinicalProspective Cohort Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair and Ovarian Function Recovery After Induced AbortionPrimary completion
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes8
- Pregnancy Complications6
- Adaptive Immunity1
- Cardiovascular Diseases1
- Cardiovascular System1
- Cytokines1
- Gastrointestinal Microbiome1
- Glucagon-Like Peptide-1 Receptor Agonists1
- Histocompatibility, Maternal-Fetal1
Leading journals6
- Frontiers in immunology3
- Anesthesiology1
- Archives of gynecology and obstetrics1
- BMJ (Clinical research ed.)1
- Cytokine & growth factor reviews1
- International journal of molecular sciences1
Leading researchers8
- Lu X2
- Abu-Raya B1
- Alexander EK1
- Ardizzone S1
- Armuzzi A1
- Auvinen J1
- Barbaresi WJ1
- Barreiro-de Acosta M1
Affiliations (unnormalised)6
- Academic Center for Thyroid Diseases1
- Almazov National Medical Research Centre1
- and Clinical Pharmacology1
- BC Children's Hospital Research Institute1
- Beth Israel Deaconess Medical Center1
- Cancer Institute1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Disease profile
A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.
Pregnancy complications are conditions or pathological processes associated with pregnancy. They can arise during pregnancy or after delivery and range from minor discomforts to serious diseases requiring medical intervention. The category includes disorders occurring in pregnant females as well as pregnancies in females who already have diseases.
The grounding supports a broad, heterogeneous aetiology rather than a single cause. Pregnancy complications can reflect abnormal implantation or placentation, failure of endometrial decidualization, and immunological imbalance at the maternal-fetal interface. They may also occur in the setting of maternal disease, including thyroid dysfunction and thyroid autoimmunity, which are associated with preterm birth.
A successful pregnancy depends on coordinated maternal-fetal exchange and a tightly regulated immune balance that permits fetal tolerance while preserving defense against infection. Disruption of decidualization, angiogenesis, immune tolerance, or trophoblast invasion can lead to abnormal implantation/placentation and adverse pregnancy outcomes. The literature also describes dynamic changes in immune cells at the maternal-fetal interface as part of the biology of normal and pathological pregnancy.
Maternal hypothyroidism and hyperthyroidism are supported risk factors for preterm birth. Thyroid autoimmunity and milder thyroid function test abnormalities are also discussed as possible risk factors, although their association with preterm birth is described as controversial. More generally, immune dysregulation during pregnancy and pre-existing maternal disease are relevant risk contexts.
The supplied grounding supports diagnosis and drug therapy as major literature themes, but it does not provide a specific treatment standard across pregnancy complications as a whole. It does indicate that management may involve screening and diagnostic evaluation, including use of the Edinburgh Postnatal Depression Scale for detecting major depression in pregnant and postpartum women. Beyond that, no general modality or drug-class treatment can be stated from the provided material.
AI-generated summary grounded in MeSH and 6 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.
Reference
Authoritative identity, definition & identifiers.
Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.